Ziemer Ophthalmic Systems AG

FDA Clearance for the FEMTO Z8 NEO

Ziemer Ophthalmic Systems received FDA clearance for its latest femtosecond laser, the FEMTO Z8 NEO - the successor of the unique Multipurpose Femtosecond Laser LDV Z8. 

THE FEMTO Z8 NEO. The outstanding multipurpose FEMTO laser platform for refractive, therapeutic and cataract surgery.

THE FEMTO Z8 NEO. The outstanding multipurpose FEMTO laser platform for refractive, therapeutic and cataract surgery.

Ziemer Ophthalmic Systems received FDA clearance for its latest femtosecond laser, the FEMTO Z8 NEO - the successor of the unique Multipurpose Femtosecond Laser LDV Z8. 

The FEMTO Z8 NEO provides advanced hardware as well as new and improved software applications. The newly designed platform offers substantial improvements on performance, usability and patient comfort. Precision and reliability were optimized by a new laser source and monitoring system. 

A new Slim handpiece in combination with an improved vacuum system ensures an enhanced docking experience and better fit to the patient, even for the most challenging cases. Improved software applications, and a new and more intuitive user guidance provides an enhanced workflow which results in a greater benefit for the surgeon and the patient.

“With the FDA Clearance for the FEMTO Z8 NEO we are bringing our most versatile and best performing Femtosecond Laser to the United States. The FEMTO Z8 NEO is a symbol for innovative, multipurpose technology in the entire ophthalmic industry.” explains Frank Ziemer, CEO and President of Ziemer Ophthalmic Systems.

Further information can be found here: www.ziemergroup.com/neo


Disclaimer: Availability for certain countries may be restricted due to regulatory requirements. Please contact Ziemer for details.

More News